Piramal Pharma Solutions | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Piramal Pharma Solutions

Home
Companies
Piramal Pharma Solutions

BRIEF

published on 11/26/2025 at 20:30, 8 days 10 hours ago

Piramal Pharma Solutions Ensures Compliance with Nitrosamine Regulations

Regulatory Standards Piramal Pharma Solutions Nitrosamine Compliance Pharmaceutical Safety Testing Capabilities
PRESS RELEASE

published on 11/26/2025 at 20:25, 8 days 10 hours ago

Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
Piramal Pharma Solutions achieves regulatory compliance for nitrosamine impurities, ensuring safety & adherence to global guidelines, enhancing capabilities & operational excellence

Regulatory Compliance Operational Excellence Patient Safety Piramal Pharma Solutions Nitrosamine Impurities
BRIEF

published on 11/19/2025 at 09:00, 15 days 21 hours ago

Piramal Pharma's Grangemouth Facility Secures Updated MHRA GMP Certifications

ADC Development GMP Certification MHRA Approval Piramal Pharma Grangemouth Facility
PRESS RELEASE

published on 11/19/2025 at 08:55, 15 days 21 hours ago

Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK receives updated MHRA GMP certificates, highlighting commitment to quality and regulatory excellence

Drug Development Piramal Pharma Solutions Bioconjugates Facility MHRA GMP Certificates Grangemouth
BRIEF

published on 10/30/2025 at 06:30, 1 month 6 days ago

Piramal Pharma Solutions Partners with IntoCell to Enhance Bioconjugate Capabilities

ADC Development Pharmaceutical Collaboration Piramal Pharma IntoCell Bioconjugates
PRESS RELEASE

published on 10/30/2025 at 06:25, 1 month 6 days ago

Piramal Pharma Solutions Formalizes Partnership with IntoCell, Expanding its Payload-Linker Platform and Bioconjugate Capabilities
Piramal Pharma Solutions partners with IntoCell to enhance bioconjugate capabilities and ADC development. Strategic agreement strengthens competitive edge and accelerates bioconjugate services

Partnership ADC Development IntoCell Piramal Pharma Solutions Bioconjugate

Accesswire

Published on 12/05/2025 at 02:35, 4 hours 15 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 4 hours 20 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 50 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 45 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 50 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 3 hours 19 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 59 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 24 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 35 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 39 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 50 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 5 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 5 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 49 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE